Ellrichmann G - Search Results

1

Evidences for Mutant Huntingtin Inducing Musculoskeletal and Brain Growth Impairments via Disturbing Testosterone Biosynthesis in Male Huntington Disease Animals.

Yu-Taeger L, Novati A, Weber JJ, Singer-Mikosch E, Pabst AS, Cheng F, Saft C, Koenig J, Ellrichmann G, Heikkinen T, Pouladi MA, Riess O, Nguyen HP. Yu-Taeger L, et al. Among authors: ellrichmann g. Cells. 2022 Nov 25;11(23):3779. doi: 10.3390/cells11233779. Cells. 2022. PMID: 36497038 Free PMC article.

2

The role of the immune system in Huntington's disease.

Ellrichmann G, Reick C, Saft C, Linker RA. Ellrichmann G, et al. Clin Dev Immunol. 2013;2013:541259. doi: 10.1155/2013/541259. Epub 2013 Jul 15. Clin Dev Immunol. 2013. PMID: 23956761 Free PMC article. Review.

3

Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease.

Ellrichmann G, Petrasch-Parwez E, Lee DH, Reick C, Arning L, Saft C, Gold R, Linker RA. Ellrichmann G, et al. PLoS One. 2011 Jan 31;6(1):e16172. doi: 10.1371/journal.pone.0016172. PLoS One. 2011. PMID: 21297955 Free PMC article.

4

Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease.

Fatoba O, Kloster E, Reick C, Saft C, Gold R, Epplen JT, Arning L, Ellrichmann G. Fatoba O, et al. Among authors: ellrichmann g. Exp Neurol. 2018 Apr;302:112-128. doi: 10.1016/j.expneurol.2018.01.001. Epub 2018 Jan 6. Exp Neurol. 2018. PMID: 29309751

5

Expression of brain-derived neurotrophic factor in astrocytes - Beneficial effects of glatiramer acetate in the R6/2 and YAC128 mouse models of Huntington's disease.

Reick C, Ellrichmann G, Tsai T, Lee DH, Wiese S, Gold R, Saft C, Linker RA. Reick C, et al. Among authors: ellrichmann g. Exp Neurol. 2016 Nov;285(Pt A):12-23. doi: 10.1016/j.expneurol.2016.08.012. Epub 2016 Aug 29. Exp Neurol. 2016. PMID: 27587303

6

The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients.

Metzger S, Walter C, Riess O, Roos RA, Nielsen JE, Craufurd D; REGISTRY Investigators of the European Huntington’s Disease Network; Nguyen HP. Metzger S, et al. PLoS One. 2013 Jul 22;8(7):e68951. doi: 10.1371/journal.pone.0068951. Print 2013. PLoS One. 2013. PMID: 23894380 Free PMC article.

7

Echogenicity of basal ganglia structures in different Huntington's disease phenotypes.

Saft C, Hoffmann R, Strassburger-Krogias K, Lücke T, Meves SH, Ellrichmann G, Krogias C. Saft C, et al. Among authors: ellrichmann g. J Neural Transm (Vienna). 2015 Jun;122(6):825-33. doi: 10.1007/s00702-014-1335-7. Epub 2014 Dec 13. J Neural Transm (Vienna). 2015. PMID: 25503829

8

Positive effect of immunomodulatory therapies on disease progression in Huntington's disease? Data from a real-world cohort.

Achenbach J, Saft C, Faissner S, Ellrichmann G. Achenbach J, et al. Among authors: ellrichmann g. Ther Adv Neurol Disord. 2022 Jul 23;15:17562864221109750. doi: 10.1177/17562864221109750. eCollection 2022. Ther Adv Neurol Disord. 2022. PMID: 35899100 Free PMC article.

9

Laquinimod treatment in the R6/2 mouse model.

Ellrichmann G, Blusch A, Fatoba O, Brunner J, Reick C, Hayardeny L, Hayden M, Sehr D, Winklhofer KF, Saft C, Gold R. Ellrichmann G, et al. Sci Rep. 2017 Jul 10;7(1):4947. doi: 10.1038/s41598-017-04990-1. Sci Rep. 2017. PMID: 28694434 Free PMC article.

10

Teaching Video NeuroImages: spinal and bulbar muscular atrophy mimicking essential tremor.

Kerasnoudis A, Ellrichmann G, Gold R, Saft C. Kerasnoudis A, et al. Among authors: ellrichmann g. Neurology. 2012 Feb 7;78(6):e41. doi: 10.1212/WNL.0b013e318245d2bd. Neurology. 2012. PMID: 22311934 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters